EP3190985B1 - Occluder - Google Patents

Occluder Download PDF

Info

Publication number
EP3190985B1
EP3190985B1 EP15763304.1A EP15763304A EP3190985B1 EP 3190985 B1 EP3190985 B1 EP 3190985B1 EP 15763304 A EP15763304 A EP 15763304A EP 3190985 B1 EP3190985 B1 EP 3190985B1
Authority
EP
European Patent Office
Prior art keywords
jacket
occluder
elongate members
holder
fixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15763304.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3190985A2 (en
Inventor
Andreas MELLMANN
Jerome Bernhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carag AG
Original Assignee
Carag AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carag AG filed Critical Carag AG
Publication of EP3190985A2 publication Critical patent/EP3190985A2/en
Application granted granted Critical
Publication of EP3190985B1 publication Critical patent/EP3190985B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526—Methods of manufacturing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00867—Material properties shape memory effect

Definitions

  • the present invention relates to an occluder for occluding a passage in a body, especially to a left atrial appendage occluder.
  • a variety of devices and techniques have been developed to occlude a vessel or an opening in an organ, such as the heart, of a patient.
  • US 6 488 706 discloses a well-working implant for occluding a passage in a circulatory system.
  • This implant has its particular application as a cardiological implant by means of which it is possible, for example, to close an aperture through the atrial septum or the ventricle septum of a heart. It is arranged to be introduced with a catheter and deployed or built up at a desired location in the body.
  • This occluder comprises a plurality of thin wire-like elongate members which form a fixation structure and a single occluding body, namely a disk-like membrane, which is expanded by the fixation structure in the body passage.
  • the fixation structure is locked in its expanded state by a locking unit.
  • This locking unit comprises two locking elements which are brought together when the occluding body is expanded.
  • WO 2005/074813 discloses an occluder working with the same principle but comprising two occluding bodies which are expanded by the fixation structures. This occluder securely closes both sides of the passage.
  • this occluder further comprises a jacket which envelops at least a part or a portion of the expanding unit so that no parts of the occluder can wander within the human or animal body. This jacket also enhances the growth of the body tissue over the occluder.
  • occluders form with their twisting elongate members the fixation structure. This has the advantage that the occluders can be opened and closed at a pace given by the user. Therefore the location within the body passage can be changed until the fixation structure is locked in its expanded form by the locking unit.
  • WO 2010/151509 discloses an occluder for repair of cardiac and vascular defects or tissue openings.
  • the occluder comprises an expandable frame consisting of elastic wires and a film encapsulating the expandable wire frame to enhance cellular growth.
  • US 2002/0156499 A1 discloses an occluder with elongate members and a jacket covering the elongate members.
  • LAA left atrial appendage
  • the closure of the left atrial appendage (LAA) is a special task.
  • the LAA is a small projection from the upper anterior portion of the left atrium. Blood pooling in the LAA may arise spontaneously or as a result of atrial fibrillation. When blood pools in the LAA, blood clots can be formed. The migration of clots from the LAA to the other parts of the body can cause loss of circulation to the affected organ or, when the clots migrate to the brain, it can even cause strokes.
  • LAA is a complex and heterogeneous structure with a rather elliptical ostium, it challenges the sizing and shaping of the occluders. The occluders have to be sized and shaped individually for each patient. Since the tissue of the cardiac structure LAA is very thin and fragile, the risk of damaging the tissue when placing the occluder is permanent as well.
  • occluders may be undesirably expelled from the LAA due to forces generated by the heart beat or by atrial fibrillation.
  • occluders usually quite big and stable occluders have to be used, which makes delivering of the implant to the LAA more difficult.
  • these occluders have to remain within the LAA passage, even when they are already overgrown.
  • Occluders for LAA are for example disclosed in US 2013/0138138 , US 2011/0054515 , US 2014/0135817 , EP 2 974 953 , US 2014/0142612 , US 2013/0131717 , US 2014/0214077 , US 2006/0247680 , US 2012/0065667 , US 2014/0058371 , US 8 801 746 , US 2014/0207169 , WO 2004/0882532 and US 2012/0172927 .
  • the meshes or frameworks are spring-like or have shape-memory.
  • US 2013/0218193 discloses an implant for LAA which includes a cap that overlies the opening of the LAA connected to a bulb in the LAA. Discontinuous segmented sails attached to the cap promote tissue growth over the device. This device can be repositioned and redeployed during implantation, wherein the single parts of this occluder are not really guided during deployment.
  • LAA left atrial appendage
  • the inventive occluder for occluding a passage in a body comprises elongate members, each elongate member having a length with a first end and a second end, the first end being held in or attached to a first holder and the second end being held in or attached to a second holder.
  • the elongate members extend independently from each other between the first and the second holder and they are collectively enveloped at least over a part of their length by at least one jacket. At least one of the at least one jackets restricts a bending motion of the elongate members when their first ends are approximated to their second ends by moving the two holders relatively to each other.
  • the elongate members form a framework of the occluder, i.e. an expanding and fixation unit or structure, which expands the occluder from a compressed state into an expanded final state and which holds the expanded occluder in this state.
  • the expanded final state is achieved by approximating the two holders to each other.
  • the two holders have not to be brought into contact with each other.
  • they remain at a distance to each other or they are locked with each other such that they can still perform a movement relative to each other along the longitudinal axis, at least in one direction.
  • they are fixedly locked to each other and no relative movement is possible any more.
  • a middle part of the holder system is made of a flexible material and remains flexible.
  • the inventive occluder uses the well-working expanding system of the occluders disclosed in US 6 488 706 , US 2003/0149463 , WO 2005/074813 and WO 2012/156415 .
  • the movement of the elongate members held in two holders can be controlled in any stage of the procedure.
  • the two holders can be moved independently from each other and therefore, the occluder can be recompressed and once again expanded as often as needed. Since a guide wire can be used, the occluder can be exactly introduced at the place to be occluded in a quite easy and efficient way.
  • the jacket or cover forces the framework of the occluder, i.e. the elongate members, into its shape, when it is expanded into its final form.
  • the invention therefore allows various shapes of occluders, particularly suited for transcatheter closure of let atrial appendage (LAA).
  • Occluders having individually chosen shapes and sizes can be made from the same basic material.
  • the inventive occluder can be made to match all sizes and shapes of LAA openings.
  • the at least one jacket restricting the bending motion of the elongate members has a bell-like shape. However, other shapes can be used as well.
  • the elongate members are at least in the expanded final state of the occluder completely covered by jackets and, if applicable, by membranes.
  • This enables to use thin elongate members without the risk that they break and wander within the patient's body.
  • This allows for a broader variety of materials to be used for producing the occluder.
  • This even also allows for occluder with bioresorbable or remodelable framework and bioresorbable or remodelable cover, even when used for LAA.
  • the whole occluder can be made bioresorbable or biodegradable or bioabsorbable or remodelable.
  • LAA closure devices are endothelialized shortly after implantation. Once such devices are covered by body tissue and ingrown, the entire occluder, or at least its framework, i.e. the elongate members, becomes obsolete.
  • the tissue of the cardiac structure LAA is very thin and fragile.
  • a permanent, i.e. metallic, device bears the life long deadly risk of erosion, perforation and damaging the surrounding anatomical structures.
  • An occluder with bioresorbable or remodelable framework that goes away after endothelialization is a benefit for the patient since erosion or perforation is very unlikely to happen.
  • the cover can bioresorb or can be remodeled as well, i.e. the jackets and the membranes.
  • the other parts of the occluder are bioresorbable or remodelable as well.
  • the at least one jacket comprises pockets which extend along the length of the jacket and which comprise open ends on both facial sides. Each elongate member is arranged within such a pocket, thereby penetrating the pocket on both open ends. Each elongate member has preferably its own pocket. Depending on the kind of jacket, the elongate member is held movable within the pocket relative to the pocket and in direction of the length of the elongate member.
  • the pockets can be additionally attached to the jacket, for example sewed, welded or clamped.
  • the pockets can also be made by folding the material of the jacket and by fixing them with known means, such as sewing, welding or clamping.
  • all of the elongate members are sewed to the at least one jacket.
  • the desired shape of the occluder in its expanded state can easily be achieved.
  • the jackets restricting the motion can be called restricting jackets, the jackets allowing the bending motion can be called covering jackets.
  • Parts of the at least one membrane, if present, can also form a jacket or cover.
  • the elongate members are restricted in their bending motion by at least a portion of their length. By choosing the portion to be restricted, the shape of the occluder in its final expanded state can be chosen.
  • an LAA occluder can not be achieved by clamping on an anatomical structure like it is the case with a septal occluder.
  • the LAA is an unneeded cardiac structure without blood flow once closed.
  • an LAA occluder does not need to be flat/disc like on both sides as it is favorable for septal occluders. Only the side facing the left atrium, i.e. the proximal portion of the occluder, is preferably flat. The side lying within the LAA, i.e. the distal portion, can fill out the cavity. By doing so, the occluder is fixed within the LAA, preferably without the need for additional retention or fixation elements.
  • the occluder comprises at least a first jacket and a second jacket, wherein the portion of the length of the elongate members restricted in its bending motion is surrounded by the second jacket and wherein a portion of the length of the elongate members arranged in the first jacket is not restricted in its bending motion or less restricted than the portion of the elongate members arranged in the second jacket.
  • the occluder further comprises an occluding membrane penetrated by the elongate members, wherein the occluding membrane is deployable by a twisting motion of the elongate members when the first holder and the second holder are moved relatively to each other.
  • the membrane preferably extends in the expanded final state at least approximately perpendicular to the longitudinal axis of the occluder.
  • the membrane has preferably a thin disk-shaped form. However, it does not have to be round but can also have other cross-sections as well, such as oval.
  • the jackets can be attached to each other or to the membrane by any suitable means. Preferably they are sewed to each other. However, they can also be welded or clamped or otherwise attached to each other.
  • the jackets can also be made in one single piece, thereby forming a unitary and single-piece jacket or cover.
  • the occluding membrane is fixed to the first jacket and the second jacket is fixed to the occluding membrane, wherein the bending motion of a portion of the elongate members enveloped by the second jacket is restricted.
  • the membrane and the at least one jacket is made of one in one single piece.
  • the occluding membrane is fixed to the first jacket and the second jacket is fixed to the occluding membrane, wherein the portions of the elongate members arranged within the first jacket are fixed to the first jacket allowing movement of the elongate members relative to the first jacket and wherein the portions of the elongate members arranged within the second jacket are fixed to the second jacket allowing less or no movement relative to the second jacket, so that the bending motion of these portions of the elongate members is restricted by the second jacket.
  • the first jacket allows a twisting motion of the portions of the elongate members enveloped by the first jacket.
  • the occluder comprises a third jacket wherein the third jacket is fixed to the second jacket on a side opposite to the occluding membrane and wherein the third jacket allows more motion of the portion of the elongate members enveloped by this third jacket.
  • a preferred occluder with at least some of the above mentioned features has a distal portion that adapts to the LAA anatomy and is thereby fixed within the LAA cavity. It has a proximal portion that configures flat and thereby seals the LAA against the left atrium.
  • the occluder comprises a first jacket, a second jacket fixed to the first jacket and a third jacket fixed to the second jacket, the first, second and third jacket forming a common bag and the elongate members being fixed along their length to the first, second and third jacket, and wherein the second jacket restricts the bending movement of the elongate members more than the first and third jacket.
  • no occluding membrane is present.
  • the elongate members are twisting with their enveloping first, second and third jackets into a cup-shaped form when the two holders are brought together.
  • hooks or other retaining means are arranged on the outside of one of the at least one jacket.
  • the at least one jacket is made of polyester fabric, bioresorbable fabric or a collagen patch.
  • the elongate members are preferably made of Nitinol or PLA (polylactide), PGA (polygycol acid) or blends thereof. Most preferably, they are made of PLGA (poly(lactic-co-glycolic acid)). If sutures or threads are used to fix the elongate members to the at least one jacket, they are preferably made of PDS (polydioxanone) or prolene.
  • the holders as well are preferably bioresorbable and preferably made of PLA (polylactide), PGA (polygycol acid) or blends thereof or of PEEK.
  • the first holder comprises a through hole with a first retaining element and the second holder comprises a stem with a second retaining element, wherein the first and the second retaining element are brought into engagement with each other in an expanded final state of the occluder.
  • This holder system can also be used in other occluders as well, such as the ones known in the state of the art..
  • first and the second holder are able to move along the stem relative to each other in the expanded final state wherein the first and the second retaining element together form an abutment of this movement.
  • a method to produce an occluder comprises the steps of
  • This expanded state is preferably the preferred final expanded state or a state similar to this final state.
  • the occluder After the occluder has or is cooled down again or shortly before it is used, the occluder can be compressed to be introduced with the sheath catheter into the patient's body. When the occluder is deployed and expanded, it will remain in its expanded final state, even without additional locking or fixation means, since it was already pre-shaped into an expanded form.
  • Another occluder which is preferably also thermally and mechanically preformed according to the method described above, comprises elongate members, each elongate member having a length with a first end and a second end, the first end being held in or attached to a first holder and the second end being held in or attached to a second holder, wherein the elongate members extend independently from each other between the first and the second holder, wherein the elongate members are collectively enveloped at least over a part of their length by at least one jacket.
  • the occluder further comprises a first occluding membrane and a second occluding membrane, the first and second occluding membranes being penetrated by the elongate members, wherein the first and second occluding membranes are deployable by a twisting motion of the elongate members when the first holder and the second holder are moved relatively to each other.
  • the first and second occluding membranes are fixed to the at least one jacket.
  • One of the at least one jacket is a middle jacket arranged between the first and the second occluding membrane.
  • the elongate members extend within this middle jacket none-attached to the middle jacket.
  • This occluder as well is especially suited for use in LAA. It has also the advantage that its shape and size can be individually chosen by still using the advantages of the guided expansion and recompression of the occluder because of the expanding structure.
  • the occluder according to the preferred embodiments is based on the implants disclosed in WO 2005/074813 , US 6 488 706 , US 2003/0149463 and especially as disclosed in WO 2012/156415 .
  • the main principle of the occluder mechanism according to this state of the art is shown in figures 1 and 2 .
  • the occluder is compressible for insertion through a delivery mechanism, such as an introduction sheath introduced in a body vein or artery or body vessel, and is deployable or expandable for occluding the passage when arrived at the position of the intended closing spot.
  • a delivery mechanism such as an introduction sheath introduced in a body vein or artery or body vessel
  • the occluder comprises at least one occluding body, here two occluding bodies or membranes 4, 5, an expanding unit consisting of a multiple of thin elongate members 1, a first holder 2 and a second holder 3.
  • the elongate members 1 are flexible and can be bent, but preferably they have no elasticity in direction of their longitudinal axis. They are preferably stiff and inextensible.
  • Each elongate member 1 is thin and made as a unitary single piece with a first end and a second end. The first end is attached to or held in the first holder 2. The second end is attached to or held in the second holder 3.
  • the elongate members 1 are arranged separate from each other and are not directly connected to each other; i.e. they are preferably separate wires or filaments and not part of a net or otherwise connected.
  • the elongate members 1 When the two holders 2, 3 are brought together, the elongate members 1 are compressed longitudinally. In the embodiments according to the state of the art shown in figures 1 and 2 , they automatically bend and twist sideways to be formed into two circular or loop shapes, similar to a flower, a propeller or an umbrella. These twisted shapes form fixation structures. These structures lay, when the occluder is implanted, on the surrounding tissue on both sides of the passage to be closed and fix the occluder at this position.
  • the two holders 2, 3 have locking elements which lock the occluder in this expanded shape and therefore lock the fixation structures in their shapes.
  • the first and second occluding bodies 4, 5 are thin membranes, which are located between the two holders 2, 3. They are preferably round, disk-shape and almost flat. They are made of a flexible material so that they can be folded or compressed when introduced into the introduction sheath. In the extended and deployed state of the occluder, they are extended as well, at least an inner region of the membranes being expanded into a round, disk-shaped form. Preferably, they are usually not tense in this expanded position so that they can abut the surrounding tissue of the passage to be closed. In the figures, the occluding bodies appear to be quite stiff and their compressed and actual flexible shapes are not realistically shown.
  • the occluding bodies 4, 5 extend in a radially manner from the longitudinal axis of the elongate members 1. Preferably they are arranged concentrically to this axis. Also preferably, both membranes are identical and their distance to their neighboring holder 2, 3 is identical. Each occluding body 4, 5 comprise a central hole 40. These holes 40 as well as corresponding holes in the two holders 2, 3 are penetrated by a guide wire when the occluder is introduced with an introduction sheath into the body passage.
  • the occluding bodies 4, 5 comprise on their circumference holes which are penetrated by the elongate members 1.
  • the holes are preferably arranged in evenly distances from each other.
  • the elongate members 1 preferably comprise fixation bushes 10 on at least one, preferably on both sides of the membranes 4, 5, which enable the membranes 4, 5 to move for only a short distance along the elongate members 1.
  • Theses bushes 10 can also be used as X-ray markers, especially when the elongate members are invisible for X-ray.
  • the bushes 10 are preferably made of metal, such as platinum-iridium or of a degradable but X-ray-visible material such as a blend of a polymer with BaS.
  • the occluding bodies 4, 5 divide each of the elongate members 1 in three portions.
  • a first portion lies between the first holder 2 and the first membrane 4.
  • a second portion lies between the two membranes 4, 5 and the third portion lies between the second membrane 5 and the second holder 3.
  • the first and third portions form in the expanded and twisted position the first and second fixation structure.
  • the second portion has in this state a coil-like or stent-like shape.
  • at least the first and third portions of the elongate members 1 have the same length.
  • the flower-like fixation structures can be surrounded by protecting jackets 6, 7.
  • jackets When jackets are used, the holes in the membranes 4, 5 for penetration by the elongate members 1 are preferably arranged at a substantial distance to their circumferential edge, giving enough material on the outer circumference of the membranes to connect the jackets 6, 7.
  • the elongate members 1 can move relative to the jackets 6, 7, wherein the jackets 6, 7 are loosely attached to at least some of the elongate members by sutures or threads 8, 9.
  • the jackets 6, 7 are sewed to the first and second membranes 4, 5.
  • the sewing seams have the reference numbers 60 and 70.
  • the elongate members 1 can still twist into their flower-like shape.
  • Figures 3 to 7 show a first embodiment of an inventive occluder especially capable to be used for closing a left atrial appendage (LAA).
  • the expanding structure is the same as described above. It comprises a multiple of thin elongate members 1, wherein each elongate member 1 is attached or held with one end in the first holder 2 and with the other end in the second holder 3.
  • the occluder comprises 3 to 10 elongate members 1, most preferably 8 elongate members.
  • the first holder 2 is a distal holder
  • the second holder 3 is a proximal holder.
  • both holders 2, 3 include markers for X-ray guidance.
  • the first holder 2 includes a Phynox-nut and the second holder 3 includes a PtIr-marker.
  • the elongate members 1 are preferably made of resorbable PLGA filaments.
  • the occluder further comprises the first membrane 4 and the first cover or jacket 6 as described above, wherein the first membrane 4 and the first jacket 6 are here, contrary to figures 1 and 2 , arranged on the proximal side of the occluder.
  • the fixation bushes 10 restricting the movement of the first membrane 4 relative to the elongate members 1 can best be seen in figure 3 .
  • the elongate members 1 penetrate the first membrane 4, their penetration region forming a circle being co-centric with the central opening 40 of the membrane.
  • the fixation bushes 10 are arranged on the outside of this penetration region, i.e. facing the distal side of the occluder.
  • “Distal" means directed to the patient
  • proximal means directed to the physician.
  • the first jacket 6 is sewed to the elongate members 1 with at least one first suture or thread 8 and the first jacket 6 is sewed to the first membrane 4.
  • the according first seam has the reference number 60.
  • the stitches made with the at least one first suture or thread 8 are guiding elements only, so that the elongate members 1 can still move relative to the first jacket 6.
  • the stitches of the at least one first suture or thread 8 extend preferably along the whole length of the portion of each elongate member 1 covered by the first jacket 6.
  • the first membrane 4 and the first jacket 6 are preferably made of woven polyester fabric or of the other materials mentioned before.
  • the first membrane 4 will therefore be called occluding membrane 4 furtheron.
  • the second jacket 7 is a restricting jacket. It is attached to the occluding membrane 4, preferably at a circle of the occluding membrane 4, the circle being bigger than the circle defined by the penetration points of the elongate members 1. I.e. the second jacket 7 covers the elongate members 1 and the bushes 10 on the distal side of the occluding membrane 4, at least when the occluder is expanded. In figure 3 , the bushes 10 can still be seen. Instead of bushes alternative fixation elements can be used as well. For example, there can be bushes on the distal or proximal side of the membrane only.
  • the second jacket 7 is preferably fixed to the occluding membrane 4 with a second seam 70, which can be quite loose.
  • the at least one thread forming the second seam 70 is more tense and the bushes 10 are now covered by the jacket 7.
  • the second jacket 7 can be made of the same basic material as the first jacket 6. This is the case in this embodiment. However, the second jacket 7 is made of a knitted material, the first jacket 6 of a woven material. The first jacket 6 is preferably stiffer and/or less elastic than the second jacket 7.
  • Figure 18 shows a basic shape of the second jacket 7, before it is closed into its generally bell-like shape.
  • each elongate member 1 is sewed to the second jacket 7 as well.
  • the at least one second suture or thread is marked with the reference number 9.
  • the stitches of this second suture or thread 9 are placed nearer to each other than the stitches of the first thread 8.
  • they are tenser, so that they are not just guiding elements but are restricting the relative movement of the elongate members 1 relative to the second jacket 7 to a minimum or are even allowing no relative movement at all.
  • each elongate member 1 is sewed to the second jacket 7 with a separate second suture or thread 9.
  • the portion of each elongate member 1 covered by the second jacket 7 is sewed to the second jacket 7 along its entire length.
  • Figure 19 shows schematically a loop 72 of seam 9 which is used to attach the elongate member 1 to the second jacket 7.
  • the elongate members 1 can be attached to the jackets 6, 7 by other means as well.
  • the jackets 6, 7 can comprise pockets 73, 74 on their inside, wherein the pockets 73, 74 are open on both ends and the elongate members 1 can be pushed or pulled into the pockets. Preferably only one single elongate member is received in a pocket.
  • Figure 20 shows a pocket 73 attached to the second jacket 7, for example it is sewed or welded or clamped to it.
  • Figure 21 shows a pocket 74 formed by the second jacket 7 itself, for example it is sewed or welded into its shape.
  • Figures 3 to 7 show how the occluder can be brought into the expanded state.
  • the occluder is almost compressed. It will be even more compressed when introduced into the delivery sheath.
  • Attached to the second holder 3 is a delivery catheter K of the delivery mechanism.
  • a control catheter P is movably arranged, which extends to the first holder 2.
  • the control catheter P is attached to the first holder 2, thereby enabling a movement of this first holder 2 independently from the movement of the second holder 3.
  • the control catheter P has a through opening for the guide wire.
  • the first and second holder 2, 3 can be brought nearer to each other.
  • the parts of the elongate members 1 arranged within the bag formed by the occluding membrane 4 and the first jacket 6 bend and twist into the flower shape known from the occluders of the state of the art.
  • the occluding membrane 4 is expanded into a shape similar to a disk, as can be seen in figure 7 , wherein these parts of the elongate members 1 remain covered by the occluding membrane 4 and the first jacket 6.
  • the bag formed by the first membrane 1 and the first jacket 6 is compressed into an expanded shape.
  • the parts of the elongate members 1 arranged within and fixed to the second jacket 7 however only slightly change their shape.
  • the movement of the elongate members 1 is mainly restricted by the geometry of the restricting second jacket 7 and by the fixation of the elongate members 1 to this restricting second jacket 7.
  • These parts of the elongate members 1 are especially hindered in their twisting motion and can therefore not take the flower-shaped form as the other parts which are arranged within the bag made of the occluding membrane 4 and the first jacket 6.
  • the second jacket 7 therefore remains elongated and takes the shape similar to a pine cone or a bell.
  • the first holder 2 and the second holder 3 are not brought into engagement with each other. They remain at a distance to each other, even in the fully expanded state as shown in figures 6 and 7 . Nevertheless, the occluder remains in this shape due to the mechanical and thermal preforming mentioned above.
  • the whole occluder, including all jackets, the holders and the membrane is assembled before it is brought into an expanded shape and then heated.
  • This expanded state is preferably the preferred final expanded state or a state similar to this final state.
  • Figures 8 and 9 show a second embodiment of the inventive occluder. It is almost identical with the one shown in figures 3 to 7 . Only the second jacket 7 has a different shape and the parts of the elongate members 1 fixed to second jacket 7 are bent into a different angle than the ones of the first embodiment, as can best be seen in figure 9 .
  • a pick-up wire W is shown which protrudes from the first holder 2. This pick-up wire W is only used for placing the occluder onto a delivery mechanism. It is then pulled out of the first holder 2 and a guide wire can penetrate the through opening of the first holder 2 in order to place the occluder at a predetermined location within the human or animal body. This also applies to all other embodiments shown.
  • FIGS 10 to 13 show a third embodiment.
  • the occluder still only comprises one single membrane, the occluding membrane 4.
  • the occluding membrane 4 is penetrated by the elongate members 1, wherein each elongate member 1 penetrates the occluding membrane 4 at a different point. These points form a co-centric circle around the central opening 40 of the occluding membrane 4, which central opening 40 can be penetrated by the control catheter P.
  • the first jacket 6 is attached to the occluding membrane 4, both forming a common bag.
  • the second jacket 7 is attached to the other side of the occluding membrane 4, as described in the above mentioned first and second embodiments.
  • the materials of the occluding membrane 4 and the first and second jackets 6, 7 are preferably the same as described above. The same applies for the threads and sutures. All these features are identical with the ones of the first and second embodiment.
  • a third jacket 6' is attached to the second jacket 7 on its distal side.
  • This third jacket 6' preferably has the same shape as the first jacket 6. Preferably, it is round with a central opening. Preferably the first jacket 6 has a bigger diameter than the third jacket 6'.
  • the first and third jacket 6, 6' are preferably made of the same material.
  • the second jacket 7 is attached to an outer circumference of the third jacket 6'. Preferably it is sewed to it. This third seam is marked with reference number 70'.
  • the elongate members 1 are preferably sewed to the third jacket 6' as well, wherein the stitches are so loose that the third thread 8' is only a guiding means but not restricting the relative movement of the elongate members 1 relative to the third jacket 6'.
  • the stitches of first and third threads 8, 8' correspond to the ones described in the first embodiment according to figures 3 to 7 . The same applies to the stitches of the second thread 9.
  • the occluding membrane 4 and the first jacket 6 allow the corresponding distal parts of the elongate members 1 to twist into a flower-shaped form.
  • the third cover or jacket 6' allows the proximal parts of the elongate members 1 to bend but they are hindered in their twisting motion by the second jacket 7 in between the first and third jackets 6, 6'.
  • the second jacket 7 has in the expanded state a shape similar to a cylinder.
  • the threads or sutures of the seams 8, 8' and 9 preferably extend along a single elongate member 1 only.
  • Figures 14 to 17 show a fourth embodiment of the inventive occluder. No membranes are present at all.
  • the elongate members 1 are enclosed within a first, second and third jacket 6, 7, 6'.
  • the first and third jackets 6, 6' are made of the same material as mentioned above. They have preferably a disk-shaped basic shape with a central hole for penetration of the control catheter P. They are both attached to the elongate members 1 with threads, wherein each elongate member 1 is sewed separately to the first and third jacket 6, 6'.
  • the second jacket 7 can be made of the same material or another material as the second jacket 7 of the embodiments mentioned above. Preferably it is made of the same material as the first and third jacket 6, 6'.
  • each elongate member 1, extending from the first to the second holder 2, 3 as a one single piece is sewed from the first to the second holder 2, 3 along its length with the same or a continuous thread.
  • the stitches are thereby so firm or tight, that the elongate member can still move in their longitudinal direction relative to the jackets but they are guided by the jackets into their bended position.
  • the elongate members 1 can not twist into the flower shape. They can and do however twist into a cup-like or concave shape as shown in figure 17 .
  • the opening of this shape is directed to the cavity of the left atrial appendage (LAA).
  • Hooks 71 or other retaining elements are preferably fixed to the outside of the jackets, on the distal side of the occluding part of the cover. This distal occluding part of the cover is generally the first jacket 6.
  • the hooks 71 engage with the body tissue of the patient, holding the occluder additionally in place.
  • the hooks 71 are preferably sewed to the material of the second jacket 7. Such hooks 71 can also be used in the other inventive embodiments described above.
  • the first and the second holder 2, 3 are preferably brought into engagement with each other and locked into one another, for example with the well known snap lock.
  • This shape of the expanded occluder has the advantage that also oval or elliptical shapes can be used as occluding shapes for closing the LAA aperture.
  • Figures 22 to 24 show another inventive occluder.
  • This occluder also comprises the elongate members 1 hold in or fixed to first and second holders 2, 3.
  • the expanding structure is therefore the same as mentioned above. Both holders 2, 3 can again be moved and controlled independently from each other.
  • the occluder comprises a first and a third jacket 6, 6' attached to a first and a second membrane 4, 5.
  • the elongate members 1 are sewed or otherwise attached to the first and second jackets 6, 6' as mentioned above; i.e. by still allowing to elongate members to move relative to the jackets 6, 6'.
  • the occluder corresponds so far to the embodiment according to figure 2 .
  • a middle second jacket 7' is arranged between the first and second membrane 4, 5 and fixed to them. Preferably it is sewed to them. Contrary to the embodiments mentioned above, the elongate members are not fixed to this second jacket 7' but are only enveloped by it. However, the shape, especially the diameter, of the second jacket 7' is preferably such that the elongate members 1 can or does not take their stent-like shape between the two membranes 4, 5 as shown in figure 1 .
  • the occluder as shown in the figures 22 to 24 is already in its fully and final expanded state. It remains in this state, even without the holders being locked into each other, since it is mechanically and thermally preformed as well. This preform is made as described above, preferably when the occluder is fully assembled.
  • Figure 25 to 31 show a preferred embodiment of a holder system and of an occluder using this holder system.
  • the occluder can be an occluder incorporating the inventive ideas as described above, namely one of the embodiments described above.
  • the inventive holder system can also be used in another kind of occluder, such as the ones mentioned in the state of the art.
  • it can be used in occluders as described in the state of the art, such as in US 6 488 706 , US 2003/0149463 , WO 2005/074813 and WO 2012/156415 .
  • the occluder system comprises the distal first holder 2 and the proximal second holder 3 as can be seen in figure 25 .
  • the first holder 2 comprises a first holder head 20 and a stem 24.
  • a through opening 22 extends through the first holder head 20 and the stem 24 and connects both ends of the first holder 2, wherein the through opening 22 comprises at its distal end an inner thread 23.
  • fixation openings 21 radially distributed around the first holder head 20. In these fixation openings 21 the elongate members 1 are hold, as can be seen in figure 28 .
  • the proximal end region of the stem 24 is formed like a surrounding retaining nose 25.
  • the stem 24 can be made of one single part. It can be made of a stiff or a flexible material. In the embodiment shown, the stem 24 consists of several parts fixedly connected to each other, wherein the middle part is preferably made of a flexible material. It is for example made of a cable tube.
  • the second proximal holder 3 comprises a second holder head 30 with fixation openings 31 for the elongate members 1 as well. It also comprises a through opening 32 connecting his ends. Instead of an inner thread, an outer thread 33 is present. The through opening 32 changes its inner diameter, wherein a circumferential retaining edge 34 is formed.
  • Figures 28 to 31 show how this occluder is brought into its expanded shape.
  • the occluder is compressed.
  • the delivery catheter K is coupled to the outer thread 33 of the proximal second holder 3.
  • the control catheter P is coupled to the inner thread 23 of the distal first holder 2, wherein this control catheter P penetrates the stem 24.
  • the control catheter P can be made of one single piece or it can, as can best be seen in figure 29 , consists of several pieces. It can especially comprise a head with an outer thread engaging the inner thread 23 of the first holder 2 and a circumferential abutting edge which abuts the proximal end of the circumferential retaining nose 25. This abutting edge prevents the control catheter P to be screwed further into the first holder head 20.
  • the two holders 2, 3 are approximated to each other by pushing the delivery catheter K forward and/or by pulling the control catheter P backwards. This accomplished until the retaining nose 25 of the first holder 2 clicks or snaps into the retaining edge 34 of the second holder 3.
  • the stem 24 remains movable relative to the inner surface of the first holder 2 along the longitudinal axis of the holder system. This movement is however restricted in one direction by the retaining action of the nose 25 and edge 34. This means that in some embodiments, the occluder can still be brought in a more expanded state but can not be brought back into the compressed state unless the connection between stem 24 and edge 34 of the second holder 3 is released.
  • the stem 24 is a guide for the opening action of the occluder when the occluder is brought into its expanded state, since the holder heads are guided along the longitudinal axis defined by the stem 24.
  • the length of the stem 24 defines the maximum distance of the two holders 2, 3. This length and therefore this distance can be chosen such, that the occluder is hold in a loaded or tensioned state; for example when the elongate members are thereby forced to bend such that they stretch the enveloping jacket. This increases the radial forces acting on the occluder.
  • the occluder according to the invention uses the well known expanding structure which can be easily handled whereby the movement of the elongate members is restricted by at least one of the jackets which envelop the elongate members.
  • the elongate members and other parts of the occluder can be made of bioresorbable material.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
EP15763304.1A 2014-09-12 2015-09-11 Occluder Active EP3190985B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14184603 2014-09-12
PCT/EP2015/070797 WO2016038174A2 (en) 2014-09-12 2015-09-11 Occluder

Publications (2)

Publication Number Publication Date
EP3190985A2 EP3190985A2 (en) 2017-07-19
EP3190985B1 true EP3190985B1 (en) 2020-03-18

Family

ID=51540995

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15763304.1A Active EP3190985B1 (en) 2014-09-12 2015-09-11 Occluder

Country Status (8)

Country Link
US (1) US10820907B2 (pt)
EP (1) EP3190985B1 (pt)
JP (1) JP6740214B2 (pt)
CN (1) CN106687053B (pt)
BR (1) BR112017004841B8 (pt)
ES (1) ES2794632T3 (pt)
RU (1) RU2704957C2 (pt)
WO (1) WO2016038174A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10441258B2 (en) * 2017-06-16 2019-10-15 Cardia, Inc. Uncoupled LAA device
US11191547B2 (en) 2018-01-26 2021-12-07 Syntheon 2.0, LLC Left atrial appendage clipping device and methods for clipping the LAA
IT201800006417A1 (it) * 2018-06-18 2019-12-18 Dispositivo cardiovascolare
WO2020198259A1 (en) 2019-03-25 2020-10-01 Laminar, Inc. Devices and systems for treating the left atrial appendage
WO2020207484A1 (zh) * 2019-04-11 2020-10-15 杭州唯强医疗科技有限公司 封堵器、封堵器紧锁系统及紧锁方法
US10925615B2 (en) 2019-05-03 2021-02-23 Syntheon 2.0, LLC Recapturable left atrial appendage clipping device and methods for recapturing a left atrial appendage clip
US11419611B2 (en) * 2019-10-24 2022-08-23 Virender K. Sharma Left atrial appendage closure device and method
CN113116410B (zh) * 2019-12-30 2022-12-02 先健科技(深圳)有限公司 密封盘及封堵装置
EP4090255A4 (en) * 2020-01-14 2024-01-10 Squadra Lifesciences Inc MEDICAL IMPLANTABLE DEVICE FOR CLOSURE OF INTERATRIUM SEPTUM DEFECTS
EP4171398A1 (en) * 2020-06-25 2023-05-03 Squadra Lifesciences, Inc Methods and apparatus for occluding the left atrial appendage

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488706B1 (en) * 1996-05-08 2002-12-03 Carag Ag Device for plugging an opening such as in a wall of a hollow or tubular organ
US6368338B1 (en) 1999-03-05 2002-04-09 Board Of Regents, The University Of Texas Occlusion method and apparatus
KR100786028B1 (ko) * 2000-02-03 2007-12-17 쿡 인코포레이티드 이식가능한 혈관장치
WO2002102280A2 (en) 2001-06-18 2002-12-27 Rex Medical, L.P. Removable vein filter
DE602004018282D1 (de) 2003-03-17 2009-01-22 Ev3 Endovascular Inc Stent mit laminierter dünnfilmverbund
EP1718213B1 (en) 2004-02-04 2007-07-11 Carag AG An implant for occluding a body passage
BRPI0506947A2 (pt) 2004-04-08 2009-06-13 Aga Medical Corp dispositivos de oclusão com flange e métodos
US8801746B1 (en) 2004-05-04 2014-08-12 Covidien Lp System and method for delivering a left atrial appendage containment device
DE102006013770A1 (de) * 2006-03-24 2007-09-27 Occlutech Gmbh Occlusionsinstrument und Verfahren zu dessen Herstellung
EP2004068B1 (en) 2006-03-31 2018-08-15 W.L. Gore & Associates, Inc. Deformable flap catch mechanism for occluder device
WO2008036384A2 (en) * 2006-09-21 2008-03-27 Synecor, Llc Stomach wall closure devices
US20080077180A1 (en) * 2006-09-26 2008-03-27 Nmt Medical, Inc. Scaffold for tubular septal occluder device and techniques for attachment
US9005242B2 (en) * 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
US20090171386A1 (en) 2007-12-28 2009-07-02 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US9693780B2 (en) 2009-06-17 2017-07-04 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9636094B2 (en) 2009-06-22 2017-05-02 W. L. Gore & Associates, Inc. Sealing device and delivery system
US20110054515A1 (en) 2009-08-25 2011-03-03 John Bridgeman Device and method for occluding the left atrial appendage
BR112012033782A2 (pt) 2010-07-02 2017-06-20 Javois Alex dispositivo de oclusão do apêndice atrial esquerdo
US9186152B2 (en) 2010-11-12 2015-11-17 W. L. Gore & Associates, Inc. Left atrial appendage occlusive devices
EP2524653A1 (en) * 2011-05-17 2012-11-21 Carag AG Occluder
CN102805654B (zh) 2011-06-01 2014-04-02 先健科技(深圳)有限公司 左心耳封堵器
JP2014533970A (ja) 2011-11-09 2014-12-18 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 閉塞デバイス
US8758389B2 (en) 2011-11-18 2014-06-24 Aga Medical Corporation Devices and methods for occluding abnormal openings in a patient's vasculature
US9554804B2 (en) 2012-02-21 2017-01-31 Cardia, Inc. Redeployable left atrial appendage occlusion device
EP3900648A1 (en) * 2012-07-13 2021-10-27 Boston Scientific Scimed, Inc. Occlusion device for an atrial appendage
WO2014031903A1 (en) 2012-08-22 2014-02-27 Krishnan Subramaniam Chitoor Methods and systems for accessing a pericardial space and preventing strokes arising from the left atrial appendage
US20140135817A1 (en) 2012-11-14 2014-05-15 Boston Scientific Scimed, Inc. Left atrial appendage closure implant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
CN106687053B (zh) 2019-06-28
ES2794632T3 (es) 2020-11-18
US20170258475A1 (en) 2017-09-14
BR112017004841B1 (pt) 2022-05-03
RU2704957C2 (ru) 2019-10-31
BR112017004841A2 (pt) 2017-12-12
BR112017004841B8 (pt) 2022-06-28
WO2016038174A3 (en) 2016-05-19
JP6740214B2 (ja) 2020-08-12
EP3190985A2 (en) 2017-07-19
US10820907B2 (en) 2020-11-03
JP2017526451A (ja) 2017-09-14
WO2016038174A2 (en) 2016-03-17
CN106687053A (zh) 2017-05-17
RU2017110757A (ru) 2018-10-15
RU2017110757A3 (pt) 2019-05-28

Similar Documents

Publication Publication Date Title
EP3190985B1 (en) Occluder
EP2709534B1 (en) Occluder
US9017373B2 (en) Septal closure devices
US20170252024A1 (en) Percutaneous catheter directed collapsible medical closure device
CN106994030B (zh) 左心耳封堵器
US20170340336A1 (en) Closure device suitable for closing the atrial appendage
EP3054855B1 (en) Occluder
CN110420044B (zh) 封堵装置
US20190328374A1 (en) Trans-septal closure device
WO2020056058A1 (en) Devices and methods for closing openings in tissue structures
CN211022807U (zh) 封堵装置
CA3126178A1 (en) Vascular implant with anchor member
US20210169497A1 (en) Medical material
US20220257224A1 (en) Occluder medical device
US20210386415A1 (en) Medical material

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170314

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MELLMANN, ANDREAS

Inventor name: BERNHARD, JEROME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190517

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BERNHARD, JEROME

Inventor name: MELLMANN, ANDREAS

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20191017

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015049035

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1244996

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200415

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ISLER AND PEDRAZZINI AG, CH

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200618

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20200318

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200619

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200618

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200812

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200718

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1244996

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200318

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2794632

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20201118

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015049035

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

26N No opposition filed

Effective date: 20201221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200911

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200911

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200318

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230519

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20230908

Year of fee payment: 9

Ref country code: IT

Payment date: 20230921

Year of fee payment: 9

Ref country code: GB

Payment date: 20230920

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230928

Year of fee payment: 9

Ref country code: DE

Payment date: 20230920

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20231124

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20231001

Year of fee payment: 9